Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Long-Term Deferred Tax (2022 - 2023)

60 Degrees Pharmaceuticals (SXTP) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $1.0 million as the latest value for Q2 2023.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $1.0 million in Q2 2023 year-over-year; TTM through Jun 2023 was $1.0 million, a N/A change, with the full-year FY2022 number at $3.3 million, changed N/A from a year prior.
  • Long-Term Deferred Tax was $1.0 million for Q2 2023 at 60 Degrees Pharmaceuticals, down from $3.3 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $3.3 million in Q4 2022 to a low of $1.0 million in Q2 2023.